China SXT Pharmaceuticals, Inc. (SXTC) Financials

SXTC Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 ? ?
June 30, 2023 29.6 million 14.9 million
March 31, 2023 29.6 million 14.9 million
Dec. 31, 2022 29.6 million 14.9 million

SXTC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 ? ?
June 30, 2023 417798 138643
March 31, 2023 ? ?
Dec. 31, 2022 208900 138643

SXTC Net Income

No data available :(

SXTC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 - - -
June 30, 2023 17.4 million - -
March 31, 2023 17.4 million - 306050
Dec. 31, 2022 17.4 million - -

SXTC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 ?
June 30, 2023 11.4 million
March 31, 2023 11.4 million
Dec. 31, 2022 431630

SXTC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - - - -
June 30, 2023 50569 - 2.2 million 57643
March 31, 2023 - - - -
Dec. 31, 2022 25284 - 2.2 million 57643

SXTC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - -
June 30, 2023 763391 426804
March 31, 2023 - -
Dec. 31, 2022 381696 213402

SXTC

Price: $1.57

52 week price:
1.25
1047.00

Earnings Per Share: -57.15 USD

P/E Ratio: -0.04

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: China

Volume: 340232

Market Capitalization: 1.4 million

Links: